Smith Christopher M has filed 17 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 32500 shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. ($PACB) on June 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 4, 2025 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | Smith Christopher M | Director | A | Stock Option (right to buy) | 32500 | $0.00 | 32,500.0000 | 297,852,228 | 9999.99% | 0.01% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | F | Common Stock | 14067 | $0.00 | 641,585.0000 | 128,461,383 | 2.15% | 0.01% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | M | Restricted Stock Unit | 57413 | $0.00 | 210,953.0000 | 128,461,383 | 21.39% | 0.04% |
| Feb. 23, 2025 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | M | Common Stock | 57413 | $0.00 | 655,652.0000 | 128,461,383 | 9.60% | 0.04% |
| Jan. 30, 2025 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | Smith Christopher M | Director | A | Common Stock | 54099 | $0.00 | 54,099.0000 | 0 | 9999.99% | 0.00% |
| Jan. 30, 2025 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | $PACB | Smith Christopher M | Director | A | Stock Option (right to buy) | 72901 | $0.00 | 72,901.0000 | 0 | 9999.99% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | M | Common Stock | 48063 | $0.00 | 650,282.0000 | 0 | 7.98% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | F | Common Stock | 18913 | $14.86 | 631,369.0000 | 0 | 2.91% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | M | Restricted Stock Unit | 48063 | $0.00 | 96,127.0000 | 0 | 33.33% | 0.00% |
| Aug. 15, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | F | Common Stock | 33130 | $0.00 | 646,302.0000 | 0 | 4.88% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | M | Common Stock | 48063 | $0.00 | 650,282.0000 | 0 | 7.98% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | M | Common Stock | 48063 | $0.00 | 679,432.0000 | 0 | 7.61% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | M | Restricted Stock Unit | 48063 | $0.00 | 268,366.0000 | 0 | 15.19% | 0.00% |
| May 11, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | F | Common Stock | 18913 | $14.86 | 631,369.0000 | 0 | 2.91% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | A | Restricted Stock Unit | 172239 | $0.00 | 316,429.0000 | 0 | 119.45% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | A | Stock Option (Right to Buy) | 287940 | $0.00 | 287,940.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2024 | NEOGENOMICS INC | $NEO | Smith Christopher M | Chief Executive Officer | A | Performance Stock Unit | 172240 | $0.00 | 316,430.0000 | 0 | 119.45% | 0.00% |